Simmunome Inc.
PrivateLast Round
Accelerator
Jun 20, 2025
Total Funding Raised
$1.89M
Company Overview
Simmunome Inc. operates in Healthcare & Life Sciences and is based in Montreal. Its latest recorded funding round was an Accelerator round in June 2025.
Simmunome Inc. is a biotechnology company that provides an AI-driven SaaS platform for disease simulations to predict clinical trial outcomes and improve drug discovery.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Simmunome Inc. Comparables
Compare Simmunome Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| VeriSIM Life | 86% | |
| CytoReason | 79% | |
| Aitia | 78% |
For institutional investors. Book with your work email.
Simmunome Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Jun 20, 2025 | ||||
| Grant | Feb 28, 2025 | ||||
| Pre Seed | Sep 18, 2023 | ||||
| SAFE | Mar 7, 2023 |
For institutional investors. Book with your work email.
Simmunome Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Génome Québec | Grant |
| Sandpiper Ventures | Pre Seed |
| BKR Capital | Pre Seed |
| Consortium Québécois sur la découverte du médicament | Accelerator |
| Accélérateur de création d'entreprises technologiques | Pre Seed |
| Theodorus | Pre Seed |
| Fonds d'investissement Eurêka | Pre Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- May 18, 2026
Monthly visitors increased 115% MoM.
- Jun 20, 2025
$100K raised from Merck and CQDM.
For institutional investors. Book with your work email.
Simmunome Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Simmunome Inc.'s valuation, stock price, and market status.
Is Simmunome Inc. a public or private company?
Simmunome Inc. is a private company.
What is the current stock price of Simmunome Inc.?
Simmunome Inc. is a private company, so its shares have no public market price. Caplight tracks Simmunome Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Simmunome Inc. worth (valuation)?
Valuation information for Simmunome Inc. is not publicly available.
Can I buy Simmunome Inc. stock?
Simmunome Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Simmunome Inc.'s last funding round?
Simmunome Inc.'s most recent funding round was Accelerator on June 20, 2025.
Who are the main investors in Simmunome Inc.?
Key investors in Simmunome Inc. include Theodorus, Fonds d'investissement Eurêka.
Will Simmunome Inc. IPO soon?
No public IPO plans have been announced for Simmunome Inc..
How can I track Simmunome Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Simmunome Inc.'s shares on secondary markets.